Cision PR Newswire

Putting Young Innovators Center Stage: Leaders In Future Tech+ Wraps with ¥526 Million in Investment Intentions and 31 Enterprise Landings

NANJING, China, Nov. 8, 2026 /PRNewswire/ -- On November 7, the grand finale of Leaders In Future Tech+ — a documentary sci-tech innovation program jointly produced by China Media Group, the Ministry of Education, and the Nanjing Municipal People's Government — aired as the Youth Innovation Carnival. ...

Blokees made its debut at CCXP México 2025, Officially Enters México Market

SHANGHAI, June 1, 2025 /PRNewswire/ -- On May 30, 2025, the most influential pop culture exhibition in Latin America, CCXP Mexico 2025, grandly opened...

InxMed Announces Promising Phase Ib/II Clinical Data for Ifebemtinib + KRAS G12C inhibitor in KRAS G12C-Mutant Solid Tumors at ASCO 2025

NANJING, China, June 1, 2025 /PRNewswire/ -- InxMed Co., Ltd, a clinical-stage biotechnological company, pioneering therapies to transform cancer treatment, released latest clinical data from a Phase Ib/II clinical...

Tianfu Rapoil Shines at Hong Kong Hometown Market Carnival

HONG KONG, June 1, 2025 /PRNewswire/ -- This is a report from Xinhuanet: Co-organized by 30 provincial-level hometown associations in Hong Kong, the...

ASCO 2025 Oral Presentation: Innovent Biologics Announces Updated Data of IBI363 (First-in-class PD-1/IL-2α -bias Bispecific Antibody Fusion Protein) from Phase 1 and 2 Clinical...

SAN FRANCISCO and SUZHOU, China, June 1, 2025 /PRNewswire/ -- Innovent Biologics, Inc (Suzhou) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and...

Zeekr Group Announces May 2025 Delivery Update

HANGZHOU, China, June 1, 2025 /PRNewswire/ -- ZEEKR Intelligent Technology Holding Limited ("Zeekr Group" or the "Company") (NYSE: ZK), the world's leading premium new...

Breakthrough Clinical Data for LBL-024 in First-Line Treatment of Advanced EP-NEC Unveiled at 2025 ASCO Oral Session

NANJING, China, May 31, 2025 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs") today announced the presentation of groundbreaking clinical data from a...